Early start of opicapone in Parkinson&#39;s disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations.

Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL

http://www.ncbi.nlm.nih.gov/pubmed/41473225

Angelo Antonini; Daniel Ramos; Fabrizio Stocchi; Georg Ebersbach; Helena C Brigas; Jaime Kulisevsky; Joaquim J Ferreira; Joerg Holenz; José Francisco Rocha; Miguel M Fonseca; Olivier Rascol; Werner Poewe

Dec 31, 2025